Healthcare & Life Sciences
Prof. Dr. Sai Reddy
Switzerland
Prof. Dr. Sai Reddy, a founder from Switzerland, has reached 1 investor with his startup, Engimmune Therapeutics. Engimmune Therapeutics is currently classified as alive. Reddy has founded 1 startup. Data sourced from Brouky Intelligence.
Startups
1
Investors reached
1
Best outcome
alive
Companies
- Engimmune Therapeutics
See full startup history, investor graph & comparable founders
Brouky tracks 2,000+ founders across their entire portfolio history with investor connection maps.